VHTVanguard Health Care ETF


$ 261.74 $ 3.54 (1.37 %)    

Friday, 31-May-2024 15:55:08 EDT
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 262.45
$ 260.77
$ 261.09 x 100
$ 262.50 x 100
$ 260.16 - $ 261.74
$ 220.78 - $ 271.53
135,898
na
na
$ 0.79
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 upward-trajectory-for-biotechpharma-ma-sector-trends-towards-pre-pandemic-levels-forecasts-positive-for-2024

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 bill...

 sp-500-stuck-in-4600-4800-limbo-for-2024-wells-fargo-pinpoints-3-favored-sectors-for-next-year

Wells Fargo Investment Institute has a 4600-4800 year-end 2024 target for the S&P 500 Index and 2000-2200 for the MSCI EAFE...

 analysis-autoworkers-are-a-missing-piece-in-the-october-jobs-report-heres-why-that-matters

While the markets are focussing on the October jobs report missing expectations, here's a missing piece that may prove them...

 lab-developed-tests-under-fda-scrutiny-what-it-means-for-startups

A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests ...

 from-ai-to-obesity-drugs---global-pharma-has-700b-for-ma-and-investments-goldman-sachs

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&...

Core News & Articles

The National Institutes of Health (NIH) has halted a trial evaluating the safety and effectiveness<

 white-house-says-administration-has-finalized-medical-insurance-transparency-rule

-Reuters

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION